About Us

  25 years of commercial strategy experience in Pharma & Biotech.

Prior to becoming a Co-Founder of FirstMileBio, Christian founded Cogent Healthcare, a Biotech/Pharma Strategy Consulting Company. He was Partner at Peppers & Rogers Group, leading their Health Care / Pharmaceutical practice. As Vice President at Braun Consulting, Christian managed the Customer Strategy practice. At Informa, he was responsible for growing the HC consulting practice by leveraging Informa’s data / business intelligence units to strengthen business strategy consulting.

 linkedin.com/in/christianneckermann 

Strategic Consultant with 20+ years of international Commercial Pharma experience.

Prior to becoming a Co-Founder of FirstMileBio, Stefan started Cogent Europe. He held commercial roles of increasing responsibility at Amgen in both Germany and Europe, focusing on the Rheumatology and Anemia franchises. He then joined Nycomed / Takeda in a global role leading thepre-launch portfolio team and later overseeing lifecycle management through LOE of its lead blockbuster asset in Gastroenterology. Most recently, he played a leading role in establishing Cubist Pharmaceuticals’ EU presence before its acquisition by Merck MSD, where he was part of the Global Antibiotic Franchise.

 linkedin.com/in/stefan-zillikens 

  25 years of global strategic and operational industry and consulting experience in early stage and mature biotech cos.

 With over 25 years of experience in the BioTech and Pharma Industry, Shilpa has established and ran her own consulting and commercial services company developing and bringing therapeutic and medical device innovation to market for over a decade. On the backdrop of holding integral roles in industry in commercialization, product development and business strategy for rare, specialty, CNS, cardiovascular, oncology and metabolic diseases. Shilpa has successfully launched 10 and managed over 90 brands, delivering P&Ls ranging from $100M to $2.5B with budgets from $1M to $250M. She has also designed and operationalized commercial strategies from early drug discovery through commercialization, leveraging her expertise in marketing, sales, market access, product development and go to market strategy. Shilpa is passionate about changing the future for patients and exceeding goals through innovative strategy, leadership, and flawless execution. 

 https://www.linkedin.com/in/shilpauparikh/

  20 years of global strategy & operational experience in biotech.

Prior to becoming a Co-Founder of FirstMileBio, Markus served as key member of the commercial team at Cytokinetics and was involved in driving board level discussions around the commercial future of the company. Markus is the founder of Enginologi, a commercial AI for biotech/pharma companies. Prior to that, he served in various US and international marketing and commercial operations roles at Biogen. Markus spend half a decade in strategy and operational consulting at ZS Associated and Booz & Co. He is also a Co-Founder of AdPilot, a company delivering accountability to advertising spend to CPG companies.

 linkedin.com/in/markushauserbiotech 

25+ years of commercial strategy experience in biopharma with 20 years in US and global market access pricing and reimbursement strategy.

Dan founded

SciMax Market Access Consulting, He works with biopharma, diagnostic and medical device companies to develop and implement strategies to improve access and pricing opportunities. Dan started his career at Pfizer and has held Market Access leadership roles with large, mid-size, small and pre-commercial global biopharmaceutical manufacturers and life science consulting firms, such as Daiichi-Sankyo, Aptalis, Celgene/Receptos, ICON and Cytokinetics. In these roles, he worked on rare and chronic disease assets across multiple therapeutic areas from pre-clinical through launch and beyond. Specializing in small and clinical stage organizations, Dan has extensive experience in building market access, pricing, contracting strategies and operations.

  linkedin.com/in/dan-cole-biotech-access 

  35+ years of Marketing and Sales Experience in biotech and pharma.

Before establishing his consulting practice, Mike served on the Commercial Leadership Team at Cytokinetics, where he helped build the commercial organization, align processes with cross‑functional partners, and develop go‑to‑market strategies for pipeline products. He also created and led the Thought Leader Liaison team, engaging key opinion leaders in priority disease areas. Mike began his career at Merck, holding leadership roles in U.S. and Global Marketing, Marketing Operations, and U.S. Sales. Following his retirement from Merck, he supported the launch of several KOL and strategic consulting firms.

   linkedin.com/in/michael-petro-aa53994 

 35 years of new product development & global marketing experience.

 Prior to FirstMileBio, David founded Bishop & Rook New Product Planning to partner with clinical-stage biotech companies and perform the full spectrum of new product planning and CCO responsibilities prior to establishment of a complete C-Suite staff.  He is focused on creating and executing strategic plans for: market segmentation; brand positioning; market development; access & reimbursement; and opinion leader management. He also brings deep experience in providing input to clinic al program design to successfully differentiate brands, fully leverage value propositions, and encourage payers to pay.

David developed his breadth of commercial capabilities through a long career at Merck, where he was deeply involved in new product development and commercialization. His portfolio includes: 11 brand marketing and leadership roles (several products >$1 billion in revenue); pipeline portfolio planning responsibility across multiple therapeutic areas; 4 new product and new indication launches; myriad business development and licensing deals; joint venture collaborations; pricing and reimbursement programs; manufacturing and supplying chain planning; and financial analysis and management roles. 

 linkedin.com/in/davidglatt99